- WORLD EDITIONAustraliaNorth AmericaWorld
Nov 04, 2025
Zoetis Announces Third Quarter 2025 Results
Oct 09, 2025
Zoetis Declares Fourth Quarter 2025 Dividend
More Press Releases
Aug 12, 2025
5 Biggest Pharmaceutical ETFs in 2025
More Featured Articles and Inverviews
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Latest News
Outlook Reports
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES